RNS Announcements

27 March 2017 Notice of Preliminary Results
22 February 2017 Vortex Biosciences Launches VTX-1 Liquid Biopsy
15 February 2017 Vortex Biosciences' CSO Wins SLAS Innovation Award
09 February 2017 Vortex Biosciences' CSO Finalist for SLAS Award
30 January 2017 Grant of Options to Directors
20 December 2016 New CEO appointed to Wanda
16 December 2016 Executed Warrants
18 November 2016 Netscientific: Vortex Biosciences Analysis Data
03 November 2016 Vortex Gains CE Mark and FDA Class 1 Registration
26 October 2016 Vortex Biosciences Appoints Non-Executive Director
30 September 2016 ProAxsis Gains CE Mark for its Respiratory Test
27 September 2016 NetScientific Interim Results
23 September 2016 Wanda Technology Selected by 24Hr HomeCare
12 September 2016 Glycotest strengthens IP portfolio
08 September 2016 Wanda Appoints Digital Health Non-Exec Director
06 September 2016 Notice of Interim Results
19 August 2016 Wanda Launches First Consumer App
18 August 2016 Vortex Biosciences Appoints Experts to New SAB
03 August 2016 Vortex Licenses Patents From Harvard University
28 July 2016 Change of Adviser
27 July 2016 Wanda Appoints Medical Director
22 July 2016 A to Z Home Health Care selects Wanda technologies
27 June 2016 Grant of Options to Director
15 June 2016 Result of AGM
14 June 2016 Vortex Biosciences appoints Chairman of SAB
14 June 2016 NetScientific hosts Capital Markets Day
10 June 2016 Confirmed Start Date for Ian Postlethwaite as CFO
07 June 2016 Portfolio PDS Biotechnology presents at BIO 2016
23 May 2016 Notice of AGM
18 April 2016 NetScientific's Vortex presents data at AACR
13 April 2016 PDS Biotechnology Reports Positive Phase 1 Results
07 April 2016 Annual Financial Report
05 April 2016 Netscientific Appoints Ian Postlethwaite as CFO
30 March 2016 ProAxsis Forms Scientific Advisory Board
24 March 2016 Notice of Results
16 March 2016 Wanda Forms Scientific Advisory Board
07 March 2016 Adoption of reduced disclosure framework
01 March 2016 Vortex co-founder receives US Presidential award
29 February 2016 Wanda and Dignity Health launch OncoVerse platform
17 February 2016 NetScientific appoints Prof. Stephen Smith as NED
09 February 2016 PDS Biotechnology partners with NCI
08 February 2016 Grant of Options to Director
26 January 2016 Directorate Change
20 January 2016 PDS Biotechnology adds drug development executives
06 January 2016 Glycotest Inc. appoints medical advisory board
04 January 2016 WANDA signs contract with HRS
16 December 2015 Lawrence Cohen appointed as CEO of Glycotest Inc.
14 December 2015 Appointment of Gene Walther as Vortex CEO
03 December 2015 ProAxsis' ProteaseTagT research update
30 November 2015 ProAxsis presents data to validate its immunoassay
16 November 2015 Issue of Equity
11 November 2015 Holding(s) in Company
10 November 2015 Grant of Options
06 November 2015 Result of General Meeting
06 November 2015 Result of Placing and Further Allotment of Shares
03 November 2015 Holding(s) in Company
21 October 2015 Posting of Circular
01 October 2015 Proposed Placing and Fund Raising to raise GBP 20m
01 October 2015 Half Yearly Report
18 September 2015 Divestment of Shareholding in Frontier BioSciences
16 September 2015 Holding(s) in Company
15 September 2015 Vortex BioSciences granted critical patent
09 September 2015 Steve Curd appointed as CEO of Wanda
07 August 2015 Divestment of non-core assets to align portfolio
04 August 2015 ProAxsis launches first-in-class ProteaseTag test
15 July 2015 Key patent granted for Glucosense's technology
22 June 2015 Results of Annual General Meeting
22 June 2015 AGM Statement
05 June 2015 Notification of Major Interest in Shares
05 June 2015 Notification of Major Interest in Shares
05 June 2015 Notification of Major Interest in Shares
05 June 2015 Notification of Major Interest in Shares
05 June 2015 Notification of Major Interest in Shares
28 May 2015 PDS Biotechnology reports positive Phase I results
18 May 2015 Notice of AGM and Annual Report & Accounts
15 May 2015 Capital Markets Day
11 May 2015 Dr. Francois R. Martelet appointed as CEO
07 May 2015 NetScientific invests in Neumitra
01 May 2015 NetScientific Forms New Digital Health Company
29 April 2015 NetScientific Capital Markets Day
01 April 2015 Change of Adviser
24 March 2015 Significant Progress in core Portfolio Companies
20 March 2015 Notice of Full Year Results
26 February 2015 Appointment of Non-Executive Director
16 January 2015 Directorate Change
07 January 2015 NetScientific teams up with KU Leuven
07 January 2015 NetScientific invests in DName-iT
15 December 2014 NetScientific invests in PDS Biotechnology
11 December 2014 NetScientific enters into alliance with Healthbox
08 December 2014 NetScientific invests in Breakout Labs' portfolio
17 November 2014 Holding(s) in Company
17 November 2014 Holding(s) in Company
03 October 2014 Subsidiary, Glycotest collaboration with Oncimmune
23 September 2014 Half Yearly Report
17 September 2014 Notice of Half Yearly Report
29 July 2014 NetScientific announces shareholder name change
23 July 2014 NetScientific Invests in Breakout Labs Companies
21 July 2014 TR1 - Notification of Major Interest in Shares
11 July 2014 TR1 - Notification of Major Interest in Shares
04 July 2014 Notification of Major Interest In Shares
02 July 2014 Research Programme in DNA Sequencing
09 June 2014 NetScientific plc
20 May 2014 Result of AGM
20 May 2014 AGM Statement
19 May 2014 Announcement of research agreement with Harvard
08 May 2014 Posting of Annual Report and Notice of AGM
26 March 2014 NetScientific Partners with Breakout Labs
19 March 2014 Preliminary results
13 March 2014 Notice of Results
24 February 2014 NetScientific invests in ProAxsis
30 September 2013 Director Dealings
27 September 2013 Interim results for six months ended 30 June 2013
16 September 2013 Admission to AIM and First Day of Dealings